GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » YoY EBITDA Growth

Meta Biomed Co (XKRX:059210) YoY EBITDA Growth : 39.83% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Meta Biomed Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 39.83%.

Meta Biomed Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩305.29.


Meta Biomed Co YoY EBITDA Growth Historical Data

The historical data trend for Meta Biomed Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co YoY EBITDA Growth Chart

Meta Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.90 -87.45 838.42 -34.49 70.93

Meta Biomed Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.05 56.90 166.08 -116.57 39.83

Meta Biomed Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Meta Biomed Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(610.402-357.111)/ | 357.111 |
=70.93 %

Meta Biomed Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(305.285-218.332)/ | 218.332 |
=39.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meta Biomed Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co (XKRX:059210) Business Description

Traded in Other Exchanges
N/A
Address
634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines